All Stories

  1. Artificial Intelligence Classification of Central Visual Field Patterns in Glaucoma
  2. Transient expression of Wnt5a elicits ocular features of pseudoexfoliation syndrome in mice
  3. Quantitative assessment of changes in anterior segment morphology after argon laser peripheral iridoplasty: findings from the EARL study group
  4. Factors associated with the presence of parafoveal scotoma in glaucomatous eyes with optic disc hemorrhages
  5. Ocular and Clinical Characteristics Associated with the Extent of Posterior Lamina Cribrosa Curve in Normal Tension Glaucoma
  6. Pattern of peripapillary capillary density loss in ischemic optic neuropathy compared to that in primary open-angle glaucoma
  7. Exfoliation syndrome in Northern Nigeria
  8. Glaucoma
  9. Optic Nerve Head Drusen Prevalence and Associated Factors in Clinically Normal Subjects Measured Using Optical Coherence Tomography
  10. Is Autophagy Dysfunction a Key to Exfoliation Glaucoma?
  11. The Clinical Spectrum and a New Theory of Pathogenesis of True Exfoliation Syndrome
  12. Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
  13. African Descent and Glaucoma Evaluation Study (ADAGES)
  14. Efficacy of the Amsler Grid Test in Evaluating Glaucomatous Central Visual Field Defects
  15. Visual Field Change and 24-Hour IOP-Related Profile with a Contact Lens Sensor in Treated Glaucoma Patients
  16. Systemic Associations of Exfoliation Syndrome
  17. Other Tests in Glaucoma: Multifocal Visual Evoked Potential
  18. Vision Loss With Sexual Activity
  19. Glaucoma
  20. Intraocular Pressure Rise in Subjects with and without Glaucoma during Four Common Yoga Positions
  21. Exfoliation syndrome: assembling the puzzle pieces
  22. Facts and myths of cerebrospinal fluid pressure for the physiology of the eye
  23. Author reply
  24. Biogeographic Ancestry in the African Descent and Glaucoma Evaluation Study (ADAGES): Association With Corneal and Optic Nerve Structure
  25. Why Do People (Still) Go Blind from Glaucoma?
  26. Author reply
  27. Selective Laser Trabeculoplasty
  28. Secondary Angle-Closure Glaucoma
  29. Exfoliation Syndrome and Exfoliative Glaucoma
  30. Glaucoma in the Phakomatoses and Related Conditions
  31. Authors’ Reply
  32. Living Reviews—A New Frontier for the Asia-Pacific Journal of Ophthalmology
  33. Vision loss with bending over
  34. Nocturnal Systemic Hypotension Increases the Risk of Glaucoma Progression
  35. A New Index to Monitor Central Visual Field Progression in Glaucoma
  36. Reply
  37. Angle-Closure Glaucomas
  38. Exfoliation syndrome in sub-Saharan Africa
  39. Clusterin and Complement Activation in Exfoliation Glaucoma
  40. Nd:YAG Laser Goniopuncture for Late Bleb Failure After Trabeculectomy With Adjunctive Mitomycin C
  41. Defining 10-2 Visual Field Progression Criteria
  42. Relationship Between Preferred Sleeping Position and Asymmetric Visual Field Loss in Open-Angle Glaucoma Patients
  43. Ocular and Systemic Manifestations of Exfoliation Syndrome
  44. Medical Management of Exfoliative Glaucoma
  45. Risk Calculation Variability Over Time in Ocular Hypertensive Subjects
  46. Sturge-Weber Syndrome (Encephalotrigeminal Angiomatosis)
  47. Eye Care for the Developing World
  48. Regenerative Nanomedicine for Vision Restoration
  49. Glaucoma in Myopia
  50. Exfoliation Syndrome and Glaucoma
  51. Pigment Dispersion Syndrome and Pigmentary Glaucoma
  52. Implications of new findings in the lamina cribrosa
  53. Evaluation of community eye outreach programs for early glaucoma detection in Nigeria
  54. Parafoveal Scotoma Progression in Glaucoma
  55. Enhanced Depth Imaging Optical Coherence Tomography of Optic Nerve Head Drusen
  56. Structure and Clinical Significance of Central Optic Disc Pits
  57. Progression Pattern of Initial Parafoveal Scotomas in Glaucoma
  58. Focal Lamina Cribrosa Defects Associated With Glaucomatous Rim Thinning and Acquired Pits
  59. Nanomedicine in Ophthalmology
  60. Understanding Disparities Among Diagnostic Technologies in Glaucoma
  61. In Vivo Evaluation of Focal Lamina Cribrosa Defects in Glaucoma
  62. Glaucoma and obstructive sleep apnoea syndrome
  63. Author reply
  64. 665 Glaucomatous Damage of the Macula as Revealed by Averaging Optical Coherence Tomography Data
  65. Exfoliation syndrome in Nigeria
  66. Optic disc haemorrhage and posterior vitreous haemorrhage from an acute posterior vitreous detachment
  67. Lower Corneal Hysteresis is Associated With More Rapid Glaucomatous Visual Field Progression
  68. Annual Reviews in Ophthalmology, a New Feature of the Asia-Pacific Journal of Ophthalmology
  69. Encephalotrigeminal Angiomatosis (Sturge-Weber Syndrome, Klippel-Trenaunay-Weber Syndrome)
  70. Author Reply
  71. Reply
  72. Regenerative nanomedicine and the treatment of degenerative retinal diseases
  73. Reply
  74. Reply
  75. Visual field progression outcomes in glaucoma subtypes
  76. High resolution in vivo imaging of the lamina cribrosa
  77. Ultrasound biomicroscopy of congenital iris flocculi
  78. Use of Amniotic Membrane Graft in Glaucoma Shunt Surgery
  79. Non-contact in vivo confocal scanning laser microscopy in exfoliation syndrome, exfoliation syndrome suspect and normal eyes
  80. The Water Drinking Test
  81. Automated alternation flicker for the detection of optic disc haemorrhages
  82. Bridging the Major Prospective National Eye Institute-sponsored Glaucoma Clinical Trials and Clinical Practice
  83. Iridocorneal Endothelial Syndrome in a 16-Year-Old
  84. Modified Visual Field Trend Analysis
  85. Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb
  86. Nanotechnology in ophthalmology
  87. Pigment Dispersion Syndrome Patients Do Not Have Larger-than-normal Irides
  88. Dynamic Analysis of Iris Configuration with Anterior Segment Optical Coherence Tomography
  89. β-Zone Parapapillary Atrophy and the Velocity of Glaucoma Progression
  90. Exfoliation Syndrome and Glaucoma
  91. Exfoliation (pseudoexfoliation) syndrome
  92. Pigmentary Dispersion Syndrome and Glaucoma
  93. Alternative and Non-traditional Treatments of Glaucoma
  94. Pigment Dispersion Syndrome and Pigmentary Glaucoma
  95. Sequential Glaucoma Implants in Refractory Glaucoma
  96. Baerveldt Glaucoma Implant in the Ciliary Sulcus
  97. Imaging of Descemet Membrane Detachment After Trabeculectomy Using Slit-lamp–adapted Optical Coherence Tomography
  98. Delayed intraocular pressure elevation after pupillary dilation in exfoliation syndrome
  99. Other Tests in Glaucoma: Multifocal Visual Evoked Potential
  100. In Vivo Imaging of the Cornea in a Patient with Lecithin-Cholesterol Acyltransferase Deficiency
  101. Directed Therapy for Exfoliation Syndrome
  102. Recurrent Angle-closure Glaucoma
  103. High-Resolution Ocular Imaging: Combining Advanced Optics and Microtechnology
  104. Directed Therapy for Exfoliation Syndrome
  105. Noncontact In Vivo Scanning Laser Microscopy of Filtering Blebs
  106. Tight orbit syndrome: a previously unrecognized cause of open-angle glaucoma: authors reply
  107. Serious complications of cosmetic NewColorIris implantation
  108. PROGNOSTIC FEATURES IN LASER TRABECULOPLASTY
  109. THE EFFECT OF 1.5% TIMOLOL MALEATE ON INTRAOCULAR PRESSURE
  110. Iris Morphologic Changes Related to α1-Adrenergic Receptor Antagonists
  111. Argon Laser Peripheral Iridoplasty for Topiramate-induced Bilateral Acute Angle Closure
  112. Temporal Evolution of Intraocular Pressure Elevation After Pupillary Dilation in Pigment Dispersion Syndrome
  113. Phakic pattern of exfoliation material on a posterior chamber intraocular lens
  114. Directed therapy: An approach to the improved treatment of exfoliation syndrome
  115. Biodegradable collagen matrix implant for trabeculectomy
  116. Ultrasound biomicroscopy of zonular anatomy in clinically unilateral exfoliation syndrome
  117. World Glaucoma Day, 6 March 2008: tackling the glaucoma pandemic
  118. Exfoliation Syndrome
  119. Author reply
  120. World Glaucoma Day, March 6, 2008: Tackling Glaucoma Internationally
  121. Accommodation-induced changes in iris curvature
  122. Plateau iris syndrome in a child
  123. The management of exfoliative glaucoma
  124. Argon laser peripheral iridoplasty
  125. World Glaucoma Day, 6 March 2008: tackling glaucoma internationally
  126. Modalities of Tonometry and their Accuracy with Respect to Corneal Thickness and Irregularities
  127. Dynamic Analysis of Dark–Light Changes of the Anterior Chamber Angle with Anterior Segment OCT
  128. The enigma of exfoliation syndrome
  129. The enigma of exfoliation syndrome
  130. Plateau iris syndrome in younger patients
  131. Natural compounds: evidence for a protective role in eye disease
  132. Argon Laser Peripheral Iridoplasty (ALPI): An Update
  133. Bilateral Prominent Schwalbe Ring in the Anterior Chamber in a Patient with Axenfeld-Rieger Syndrome and Megalocornea
  134. Proteomic Analysis of Exfoliation Deposits
  135. Visual Field and Intraocular Pressure Asymmetry in the Low-Pressure Glaucoma Treatment Study
  136. The angle-closure glaucomas
  137. The angle-closureglaucomas
  138. Bridging the gap: Toward a greater role for India in vision research
  139. Natural compounds: evidence for a protective role in eye disease
  140. FOUR-GENERATION FAMILIAL BENIGN FLECK RETINA
  141. Control of Filtering Bleb Structure through Tissue Bioengineering: An Animal Model
  142. Angle-closure caused by an anterior segment membrane
  143. Central Corneal Thickness is not Related to Anterior Scleral Thickness or Axial Length
  144. Rescue of failed filtering blebs with ab interno trephination
  145. Early diagnosis of exfoliation syndrome in the offspring of affected patients
  146. Identification of Retained Nucleus Fragment in the Posterior Chamber Using Ultrasound Biomicroscopy
  147. Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His
  148. Argon Laser Peripheral Iridoplasty
  149. Central Corneal Thickness Measurement in Clinical Practice
  150. Ciliary Body Thickness Increases With Increasing Axial Myopia
  151. Hypophosphorylation of Aqueous Humor sCD44 and Primary Open-Angle Glaucoma
  152. The Low-pressure Glaucoma Treatment Study (LoGTS)
  153. Exfoliation Syndrome
  154. Scanning Protocol Choice Affects Optical Coherence Tomography (OCT-3) Measurements
  155. Pigment Dispersion Syndrome - Update 2003
  156. New Concepts in the Diagnosis of Angle-Closure Glaucoma: The Role of Ultrasound Biomicroscopy
  157. Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome
  158. Assessing the treatment of angle closure
  159. Angle closure in younger patients
  160. Author reply
  161. Author reply
  162. Plasma homocysteine is elevated in patients with exfoliation syndrome
  163. Primary Trabeculectomy
  164. Discussion by Robert Ritch, MD
  165. Iridociliary apposition in plateau iris syndrome persists after cataract extraction
  166. Chronic angle-closure with glaucomatous damage
  167. Exfoliation syndrome: More than meets the eye
  168. Vascular Endothelial Growth Factor is Increased in Aqueous Humor of Glaucomatous Eyes
  169. Attempted eyelid closure affects intraocular pressure measurement in open-angle glaucoma patients
  170. Ultrasound biomicroscopy in uveitis-glaucoma- hyphema syndrome
  171. The Efficacy of Latanoprost is Independent of the Width of the Ciliary Body Face
  172. Laser surgery for angle closure glaucoma
  173. Perspective on Exfoliation Syndrome
  174. Optical coherence tomography of intacs
  175. Ultrasound biomicroscopy before and after goniosynechialysis
  176. Glaucoma drainage tube kink after pars plana insertion
  177. Diode Laser Transscleral Cyclophotocoagulation for Refractory Glaucoma
  178. The Seventh Annual Optic Nerve Rescue and Regeneration Think Tank: Immune Modulation and Gene Expression in Glaucoma
  179. Hepatocyte Growth Factor is Increased in the Aqueous Humor of Glaucomatous Eyes
  180. Author’s reply
  181. Author’s reply
  182. Exfoliation syndrome
  183. Vitreous opacities affect scanning laser polarimetry measurements
  184. Attempted eyelid closure affects intraocular pressure measurement
  185. Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank
  186. The Sixth Annual Optic Nerve Rescue and Regeneration Think Tank: Developmental Genetics in Glaucoma
  187. Exfoliation Syndrome
  188. DIRECTED THERAPY FOR SPECIFIC GLAUCOMAS
  189. High intraocular pressure and survival: the Framingham studies
  190. Low-dose 5-fluorouracil trabeculectomy as initial surgery in uncomplicated glaucoma: long-term followup11The authors have no financial interest in any device or technique described in this article.
  191. Combined exfoliation and pigment dispersion11The authors have no financial interest in any product mentioned herein.
  192. Neuroprotection: is it already applicable to glaucoma therapy?
  193. Electrophysiologic Assessment of Photoreceptor Function in Patients With Primary Open-angle Glaucoma
  194. Quantitative assessment of the anterior segment using ultrasound biomicroscopy
  195. Potential role for Ginkgo biloba extract in the treatment of glaucoma
  196. Quantitative Ultrasound Biomicroscopy
  197. Risk Factors in Pigmentary Glaucoma
  198. A Uniform Format for Ocular Imaging Devices
  199. Kinetic and Static Fixation Methods in Automated Threshold Perimetry
  200. Noninfectious crystalline keratopathy after postoperative subconjunctival 5-fluorouracil
  201. Hyphema associated with pupillary dilation in a patient with exfoliation glaucoma and warfarin therapy
  202. Sek Jin Chew, MD, PhD, FRCS
  203. The angle-closure glaucomas
  204. Pigment Dispersion Syndrome
  205. Lack of cross-reactive allergic response to brimonidine in patients with known apraclonidine allergy
  206. Cataract and Exfoliative Glaucoma
  207. Visual evoked potential assessment of the effects of glaucoma on visual subsystems
  208. Familienanamnese Glaukom und Risikofaktoren bei Pigmentglaukom - Eine klinische Studie
  209. Initial Treatment of Exfoliative Glaucoma
  210. Role of ultrasound biomicroscopy in the differentiation of block glaucomas
  211. Pericardial Patch Grafts in Glaucoma Implant Surgery
  212. Bleb-related Ocular Infection in Children after Trabeculectomy with Mitomycin C
  213. Latanoprost for Uncontrolled Glaucoma in a Compassionate Case Protocol
  214. Brimonidine
  215. ROBERT RITCH, M.D., RECEIVES 1996 HEED AWARD
  216. Going Forward to Work Backward
  217. Tissue Culture of Adult Human Retinal Ganglion Cells
  218. Glaucoma in Phakomatosis Pigmentovascularis
  219. Advances in Glaucoma Therapy: Brimonidine Tartrate
  220. Clear Corneal Graft Overlying the Seton Tube to Facilitate Laser Suture Lysis
  221. Management of Sickle Cell Disease and Hyphema
  222. Optic Coherence Tomography of Optic Disk Pit Maculopathy
  223. Should patients with anatomically narrow angles have prophylactic iridectomy?
  224. Therapeutics and Techniques
  225. Risk Factors for Ciliochoroidal Effusion after Panretinal Photocoagulation
  226. Prevent Blindness America Visual Field Screening Study: AUTHOR REPLY
  227. Neuroprotection: how is potentially applicable to treatment of glaucoma?
  228. Filtration Surgery in a Young, Aphakic, High Myope. II. Management of Postoperative Choroidal Hemorrhage
  229. Chromatic and luminance systems deficits in glaucoma
  230. Authors' reply
  231. Location of the Iris Insertion in Pigment Dispersion Syndrome
  232. Prevent Blindness America Visual Field Screening Study
  233. Short-term Efficacy of Apraclonidine Hydrochloride Added to Maximum-tolerated Medical Therapy for Glaucoma
  234. Filtration Surgery in a Young, Aphakic, High Myope. I. Anesthesia and Surgical Technique
  235. Surface-Tension Properties of Hyaluronic Acid
  236. Prevention of Blinking Alters Iris Configuration in Pigment Dispersion Syndrome and in Normal Eyes
  237. Presumed Sudden Leakage of a Pilocarpine Ocusert and Rhegmatogenous Retinal Detachment
  238. Parental History and Myopia: Taking the Long View
  239. Authors' reply
  240. Authors' reply
  241. 5-Fluorouracil in Initial Trabeculectomy
  242. Letter to the Editor
  243. Reconstruction of Filtering Blebs with Free Conjunctival Autografts
  244. Krupin Eye Valve with Disk for Filtration Surgery
  245. Corynebacterium Scleritis
  246. Ultrasound Biomicroscopy in Pigment Dispersion Syndrome
  247. Ghost Cell Glaucoma
  248. Exfoliation Syndrome???The Most Common Identifiable Cause of Open-Angle Glaucoma
  249. Oral Imipramine and Acute Angle Closure Glaucoma
  250. Management of Iridocorneal Endothelial Syndrome
  251. Chronic Uveitis and Glaucoma
  252. Asymmetric Pigmentary Glaucoma Caused by Unilateral Angle Recession
  253. Ultrasound Biomicroscopy in Pseudophakic Malignant Glaucoma
  254. Prevalence of Pigment Dispersion Syndrome in a Population Undergoing Glaucoma Screening
  255. Argon Laser Trabeculoplasty in Pigmentary Glaucoma
  256. An Intractable Problem
  257. Follow-up of Angle-closure Glaucoma Suspects
  258. Management of the Leaking Filtration Bleb
  259. Initial Treatment of Pigmentary Glaucoma
  260. Influence of Treatment Protocol on the Long-Term Efficacy of Argon Laser Trabeculoplasty
  261. Lattice Degeneration of the Retina and the Pigment Dispersion Syndrome
  262. Ophthalmology in Laos
  263. Asymmetric Pigmentary Glaucoma Resulting From Cataract Formation
  264. Filtration blebs — Function or failure, how and why?
  265. Authors' reply
  266. Plateau Iris Is Caused by Abnormally Positioned Ciliary Processes
  267. Ultrasound Biomicroscopy in Plateau Iris Syndrome
  268. Argon Laser Peripheral Iridoplasty
  269. Cataract and Advanced Open-Angle Glaucoma
  270. Authors' reply
  271. Acute Angle-Closure Glaucoma Secondary to Chlor-Trimeton
  272. Combined Cataract Extraction and Trabeculectomy
  273. Venous Stasis Retinopathy and Postoperative Hypotony
  274. Initial 5-Fluorouracil Trabeculectomy in Young Patients
  275. Argon Laser Peripheral Iridoplasty for Angle-Closure Glaucoma in Sibilings with Weill-Marchesani Syndrome
  276. Age-related Decline of Disc Rim Area in Visually Normal Subjects
  277. Rhegmatogenous Retinal Detachment After Initiation of Ocusert Therapy
  278. Posterior Polymorphous Dystrophy and Alport Syndrome
  279. Late Bleb-related Endophthalmitis after Trabeculectomy with Adjunctive 5-Fluorouracil
  280. Letter to the Editor
  281. Letter to the Editor
  282. Management of the Failing Filtering Bleb
  283. Glaucoma in Oculodermal Melanocytosis
  284. Combined Exfoliation and Pigment Dispersion Syndrome
  285. Asymmetric Pigment Dispersion Syndrome in a Patient with Unilateral Horner's Syndrome
  286. Malignant Glaucoma Following Argon Laser Release of Scleral Flap Sutures After Trabeculectomy
  287. 'Moustache Glaucoma'
  288. Authors' reply
  289. Pseudoexfoliative Fibrillopathy in the Conjunctiva
  290. Pseudophakic Pupillary Block With Angle-Closure Glaucoma in Diabetic Patients
  291. Clinical Signs of the Pseudoexfoliation Syndrome
  292. The Use of PhEA 34c in Trabeculectomy
  293. Effect of Adding Betaxolol to Dipivefrin Therapy
  294. Laser Therapy in Glaucoma
  295. Congenital Ectropion Uveae with Glaucoma
  296. A Simplified Technique for Laser Iridectomy in Blue Irides
  297. Clinical, structural, and biochemical advances in hereditary eye disorders
  298. Remission of Pigmentary Glaucoma in a Patient with Subluxed Lenses
  299. Argon Laser Treatment for Relief of Medically Unresponsive Angle-Closure Glaucoma Attacks: Reply
  300. Nonprogressive Low-Tension Glaucoma with Pigmentary Dispersion
  301. Argon Laser Treatment for Medically Unresponsive Attacks of Angle-Closure Glaucoma
  302. Argon Laser Iridectomy in Densely Pigmented Irides
  303. A Positioning Aid for Eyedrop Administration
  304. Ocular pathology of Fabry's disease in a hemizygous male following renal transplantation
  305. Proton-Beam Irradiated Epithelioid Cell Melanoma of the Ciliary Body
  306. The effect of colchicine on aqueous humor dynamics
  307. Glaucoma, 2nd ed.
  308. Epinephrine as the initial therapy in selected cases of ocular hypertension
  309. Electron Microscopic Observations of Intravitreal Cysticercus cellulosae (Taenia solium)
  310. Goniodysgenesis: A new perspective on glaucoma
  311. Continuous Wave Argon Laser Iridectomy in Angle-Closure Glaucoma
  312. Recent advances in glaucoma
  313. Symposium on Medical Therapy in Glaucoma, Documenta Ophthalmologica Proceedings Series, vol. 12
  314. Principles of quantitative perimetry: Testing and interpreting the visual field
  315. Retail Cost of Antiglaucoma Drugs in Two Cities
  316. 571 FAILURE OF FIBROBLAST ALLOGRAFT FOR ENZYME REPLACEMENT IN MUCOPOLYSACCHARIDOSIS, TYPE VI
  317. Examination and interpretation of the optic disc
  318. Wrong Drug Dispensed
  319. Inadvertent Substitution of Acetohexamide for Acetazolamide
  320. Atlas of diseases of the anterior segment of the eye, vol 5.: The crystalline lens
  321. International Glaucoma Symposium — Albi 1974
  322. A synopsis of ophthalmology
  323. Symposium on Glaucoma
  324. PEROXISOMAL ABNORMALITIES IN METABOLIC DISEASES
  325. Angle-Closure Glaucomas